-
Pro Research: Wall Street delves into Vertex Pharmaceuticals
12 May 2024 16:46 GMT
Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology firm, continues … opportunities within the evolving biotech landscape.
Market Performance … in these new drug markets could impact … Pharmaceuticals (NASDAQ:VRTX) has been a standout in the biotech …
-
A Strong Buy - Actinium Pharmaceuticals Promising AML Treatment With Targeted Radiotherapies
12 May 2024 14:20 GMT
… the inherent biotech risks. AML Solution: Business Overview Actinium Pharmaceuticals, Inc. … EU's Orphan Drug Designation, which I believe … these types of novel drugs, and insurance policies often … This first-in-class drug candidate has relatively high …
-
US bill restricting business with Chinese biotech companies extends deadline
12 May 2024 15:06 GMT
… research and manufacturing work for pharmaceutical and biotech firms worldwide.
The revised … biotech companies to lessen their reliance on China for everything from drug … US biotech supply chain — and how the legislation would jeopardise the drug …
-
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
12 May 2024 12:37 GMT
… -cap biotech with two first and best-in-class drugs on … Physicians, nurses, advanced practice providers, pharmacy, reimbursement, pathology, you name it … everybody’s aware of the drug or the support and … sort of expectations for free drug programs as we think …
-
Australia: Innovative Biotech Approach to Bladder Cancer
12 May 2024 02:58 GMT
… within UniQuest’s Queensland Emory Drug Discovery Initiative, in collaboration with … potential.
One supporter of burgeoning biotechnological endeavours has been instrumental in … and the proliferation of orphan drug formulations serve as catalysts, fostering …
-
Revised Bill Gives US Firms Time to Cut Ties With China Biotechs
11 May 2024 17:53 GMT
… biotech companies to lessen their reliance on China for everything from drug … research and manufacturing work for pharmaceutical and biotech firms around the world … US biotech supply chain – and how the legislation would jeopardise the drug …
-
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
11 May 2024 14:10 GMT
… disease. After receiving Food and Drug Administration (FDA) approval for … .com
An excellent pick for biotech stocks, Axsome Therapeutics (NASDAQ … The company’s most prominent drug is Auvelity, which is … But the potential of the drugs coming down the pipeline is …
-
Cardurion Pharmaceuticals Presents Positive Clinical Results from CARDINAL‑HF Phase 2a Clinical Trial of PDE9 Inhibitor in Patients With Heart Failure
11 May 2024 13:12 GMT
Cardurion Pharmaceuticals, Inc. (“Cardurion”), a clinical-stage biotechnology company developing … Despite the availability of drugs indicated to reduce morbidity … Cardurion Pharmaceuticals
Cardurion Pharmaceuticals is a clinical-stage biotechnology company …
-
CD BioSciences Updates Its High-Throughput Drug Screening Platforms
11 May 2024 08:38 GMT
… infective compounds, anti-neurodegenerative disease drugs, longevity compounds, and anti- … cancer drugs. Additionally, its Drosophila in … provider of innovative drug discovery solutions for pharmaceutical companies, biotech firms, and …
-
GHIT Fund announces investment of approximately US$ 10.8 million in new drug development for malaria and neglected tropical diseases
11 May 2024 09:43 GMT
… development of malaria chemoprevention drug through a partnership among … for Genetic Engineering and Biotechnology (ICGEB).
For NTDs, … ) in two projects: drug development for onchocerciasis and … by Mitsubishi Tanabe Pharma Corporation and Drugs for Neglected …